TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas

Modern Pathology

Volumn 22, Issue 10, 2009, Pages 1399-1400

  Netto, George J ^a   Lotan, Tamara ^a   Albadine, Roula ^a   Latour, Mathieu ^a   Demarzo, Angelo M ^a   Meeker, Alan ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE FUSION; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; TMPRSS2 ERG GENE;

EID: 70349662174     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.102     Document Type: Letter

References (12)

1. Esgueva R, Demichelis F, RubinMA. TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Mod Pathol 2009;22:1398-1399 (this issue).
2. Lotan TL, Toubaji A, Albadine R, et al. TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Mod Pathol 2009;22:359-365.
3. Demichelis F, Fall K, Perner S, et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007;26: 4596-4599.
4. Attard G, Clark J, Ambroisine L, et al., Transatlantic Prostate Group. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008;27:253-263.
5. Saramaki OR, Harjula AE, Martikainen PM, et al. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. Clin Cancer Res 2008;14:3395-3400.
6. Gopalan A, Leversha MA, Satagopan JM, et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res 2009;69:1400-1406.
7. Toubaji A, Albadine R, Meeker AK, et al. Chromosome 21 copy number but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocacrcinoma: a large case-control radical prostatectomy cohort analysis. Mod Pathol 2009;22(Suppl 1):189A pp.
8. Nam RK, Sugar L, Wang Z, et al. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 2007;6:40-45.
9. Nam RK, Sugar L, Yang W, et al. Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br J Cancer 2007;97:1690-1695.
10. Brinker DA, Ross JS, Tran TA, et al. Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade? J Urol 1999;162:2036-2039.
11. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-648.
12. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007;31:882-888.